Bartosz Krakowiak
YOU?
Author Swipe
View article: The differences between ambulatory and hospitalized heart failure patients who have mildly reduced or preserved ejection fractions: Lessons learned from the HF-POL study
The differences between ambulatory and hospitalized heart failure patients who have mildly reduced or preserved ejection fractions: Lessons learned from the HF-POL study Open
The HF-POL registry highlighted important differences between hospitalized and ambulatory HF patients, underscoring the need for individualized management, particularly during transitions from hospital to ambulatory care.
View article: Cardiotoxic effects of anthracyclines – a literature review
Cardiotoxic effects of anthracyclines – a literature review Open
Adverse effects associated with cancer treatment, including cancer therapy-related cardiovascular toxicity (CTR-CVT), affect patients’ quality of life and overall survival. Severe and potentially life-threatening cardiotoxicity associated …
View article: Repurposing the β<sub>3</sub>-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease
Repurposing the β<sub>3</sub>-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease Open
Importance Left ventricular (LV) hypertrophy contributes to the onset and progression of heart failure (HF), particularly for patients with pre-HF (stage B) for whom no treatment has yet proven effective to prevent transition to overt HF (…
View article: A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study Open
The risk of ischemic events gradually decreases after acute coronary syndrome (ACS), reaching a stable level after 1 month, while the risk of bleeding remains steady during the whole period of dual antiplatelet treatment (DAPT). Several de…
View article: Phrenic nerve stimulation in patients with central sleep apnea: a single‑center experience from pilot and pivotal trials evaluating the remedē System
Phrenic nerve stimulation in patients with central sleep apnea: a single‑center experience from pilot and pivotal trials evaluating the remedē System Open
We showed that PNS improved sleep metrics and QoL in patients with CSA, which is a result of multiple factors, including a comprehensive coordination between cardiology, sleep medicine, and electrophysiology. This ensures appropriate patie…
View article: InterAtrial Shunt Device (IASD®) implantation — a novel treatment method for heart failure with preserved ejection fraction
InterAtrial Shunt Device (IASD®) implantation — a novel treatment method for heart failure with preserved ejection fraction Open
Heart failure with preserved ejection fraction (HFpEF) is a condition with complex pathophysiology and clinical profile. No treatment has been proven to reduce mortality or reduce morbidity in a meaningful way. In the era of percutaneous c…